ArticleThe Lancet regional health. Western Pacific2023
Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?
Ying Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.